VOYAGER THERAPEUTICS INC (VYGR) Stock Price, Quote, News and Overview
NASDAQ:VYGR - Nasdaq - US92915B1061 - Common Stock - Currency: USD
VYGR Quote, Performance and Key Statistics
VOYAGER THERAPEUTICS INC
NASDAQ:VYGR (1/31/2025, 8:00:30 PM)
After market: 5.52 +0.07 (+1.28%)5.45
-0.16 (-2.85%)
The current stock price of VYGR is 5.45 USD. In the past month the price decreased by -3.88%. In the past year, price decreased by -26.85%.
VYGR Latest News, Press Releases and Analysis
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Voyager Reports Third Quarter 2024 Financial and Operating Results
- Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer’s; on track to generate top-line data H1...
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
LEXINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing...
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing...
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing...
VYGR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.11 | 324.98B | ||
| AMGN | AMGEN INC | 14.85 | 153.42B | ||
| GILD | GILEAD SCIENCES INC | 21.94 | 121.14B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 905.25 | 118.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.81 | 73.95B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.17B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.99B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.83B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.95B | ||
| NTRA | NATERA INC | N/A | 23.36B | ||
| BIIB | BIOGEN INC | 8.81 | 20.97B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.86B |
Related stock screener links
About VYGR
Company Profile
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. The company is headquartered in Lexington, Massachusetts and currently employs 162 full-time employees. The company went IPO on 2015-11-11. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs, all of which are in preclinical development, include Anti-Tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy Program, Tau Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program, and others. VY-TAU01 is for the treatment of Alzheimer’s disease. SOD1 Silencing Gene Therapy Program is for the treatment of ALS.
Company Info
VOYAGER THERAPEUTICS INC
75 Hayden Avenue
Lexington MASSACHUSETTS 02139 US
CEO: G. Andre Turenne
Employees: 162
Company Website: https://www.voyagertherapeutics.com/
Investor Relations: https://ir.voyagertherapeutics.com/
Phone: 18572595340
VYGR FAQ
What is the stock price of VYGR?
The current stock price of VYGR is 5.45 USD.
What is the symbol for VOYAGER THERAPEUTICS INC stock?
The exchange symbol of VOYAGER THERAPEUTICS INC is VYGR and it is listed on the Nasdaq exchange.
On which exchange is VYGR stock listed?
VYGR stock is listed on the Nasdaq exchange.
Is VYGR a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for VYGR, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of VYGR.
Does VYGR stock pay dividends?
VYGR does not pay a dividend.
What is the Price/Earnings (PE) ratio of VYGR?
The PE ratio for VYGR is 7.68. This is based on the reported non-GAAP earnings per share of 0.71 and the current share price of 5.45 USD.
What is the Short Interest ratio of VYGR stock?
The outstanding short interest for VYGR is 5.43% of its float.
VYGR Technical Analysis
VYGR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to VYGR. VYGR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
VYGR Financial Highlights
Over the last trailing twelve months VYGR reported a non-GAAP Earnings per Share(EPS) of 0.71. The EPS decreased by -42.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.8% | ||
| ROA | 6.07% | ||
| ROE | 7.84% | ||
| Debt/Equity | 0 |
VYGR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 88% to VYGR. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of -130.32% and a revenue growth -45.77% for VYGR